HomeInsightsPE

Oxygenta Pharmaceutical Ltd PE Ratio

Oxygenta Pharmaceutical Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

43.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

PE

-

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Oxygenta Pharmaceutical Ltd is 0 as of 23 Nov 15:30 PM .
  • The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 73.1 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Oxygenta Pharmaceutical Ltd

No data available

Company Fundamentals for Oxygenta Pharmaceutical Ltd

No data available

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Share Price

₹ 73.1

2.25 (3.18%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202473.1
21 Nov 202470.85
19 Nov 202474.22
18 Nov 202477.87
14 Nov 202481.96
13 Nov 202483.63
12 Nov 202485.33
11 Nov 202487.07
08 Nov 202488.84
07 Nov 202490.65

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Oxygenta Pharmaceutical Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Oxygenta Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Oxygenta Pharmaceutical Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Revenue of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Dividend Payout of Oxygenta Pharmaceutical Ltd

No data available

* All values are in %

About Oxygenta Pharmaceutical Ltd

  • Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
  • Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
  • The Company is doing contract manufacturing work for APL and also having its own production.
  • The Company is engaged in manufacture of bulk drugs.
  • It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.

Oxygenta Pharmaceutical Ltd News Hub

News

Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 20...

Read more

2024-08-16 00:00:00

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

2024-08-12 00:00:00

News

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the compan...

Read more

2024-09-18 00:00:00

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

2024-11-11 00:00:00

News

Oxygenta Pharmaceutical reports standalone net loss of Rs 2.85 crore in the September 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 2.85 crore in the quarter ended Septemb...

Read more

2024-11-15 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Oxygenta Pharmaceutical Ltd

What is the current PE Ratio of Oxygenta Pharmaceutical Ltd?

The Current PE Ratio of Oxygenta Pharmaceutical Ltd is 0.0 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Oxygenta Pharmaceutical Ltd last year?

The PE Ratio of Oxygenta Pharmaceutical Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Oxygenta Pharmaceutical Ltd indicate about its stock?

The PE Ratio of Oxygenta Pharmaceutical Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Oxygenta Pharmaceutical Ltd.

What is the PE Ratio Growth of Oxygenta Pharmaceutical Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Oxygenta Pharmaceutical Ltd grew by -% whereas, the EPS ratio grew by 107.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*